The Vitality Mammography Messaging Study

NCT ID: NCT06277141

Last Updated: 2025-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

7655 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-27

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators will be conducting a randomized controlled trial amongst members of a Wellness Program to test receipt of mammogram using the Whatsapp social media platform and testing various messages.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will be conducting a randomised control trial to test the efficacy of WhatsApp messages to increase receipt of mammography amongst eligible women who are members of the Vitality health promotion programme and are also on the Discovery Health Medical Scheme. The study will test a message that 1) has a link to a platform created by the Radiology Society of South Africa which allow members to select a range of practices to book a mammogram, against 2) a message that gives names and telephone numbers of Radiology practices in a 5 km radius of the members home address, against 3) a group with a link to an online platform as well as telephone numbers of radiology practices, against 4) a group where a standard message reminding to go for mammogram will be sent, but without names and telephone numbers of the radiology practices, against 5) a control group where no messages relating to mammography will be sent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard message

standard message reminder to screen for breast cancer.

Group Type EXPERIMENTAL

Standard message

Intervention Type BEHAVIORAL

Participants will receive standard messaging based on the Cancer Association of South Africa (CANSA) recommendation on breast cancer screening and a reminder to screen for breast cancer.

Radiology Booking Site Link

Message with an online link to a radiology practice booking site.

Group Type EXPERIMENTAL

Radiology booking site link.

Intervention Type BEHAVIORAL

Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site.

Radiology practice telephone numbers

Message with a list and telephone numbers of radiology practices.

Group Type EXPERIMENTAL

Radiology practice telephone numbers

Intervention Type BEHAVIORAL

Participants will receive a reminder to screen for breast cancer together with a list and telephone numbers of radiology practices

Control - no message

Participants will not receive any messaging regarding mammography.

Group Type NO_INTERVENTION

No interventions assigned to this group

Radiology booking site link and telephone numbers.

Message with a direct online link to a radiology practice booking site and telephone numbers of radiology practices.

Group Type EXPERIMENTAL

Radiology site link and telephone numbers

Intervention Type BEHAVIORAL

Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site and a list and telephone numbers of radiology practices

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard message

Participants will receive standard messaging based on the Cancer Association of South Africa (CANSA) recommendation on breast cancer screening and a reminder to screen for breast cancer.

Intervention Type BEHAVIORAL

Radiology booking site link.

Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site.

Intervention Type BEHAVIORAL

Radiology practice telephone numbers

Participants will receive a reminder to screen for breast cancer together with a list and telephone numbers of radiology practices

Intervention Type BEHAVIORAL

Radiology site link and telephone numbers

Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site and a list and telephone numbers of radiology practices

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Females aged 50 to 75 years, who are members of the Discovery Health Medical Plan and who are also members of Vitality and who have not had a screening mammogram in the preceding three years and who have not previously been diagnosed with breast cancer.

Exclusion Criteria

* CPA Blocks
* If member's address location, based on their Discovery profile, was further than 5km radius to the Radiologist practice
Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Discovery Vitality

OTHER

Sponsor Role collaborator

Wits Health Consortium (Pty) Ltd

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adele Walker

Role: PRINCIPAL_INVESTIGATOR

Discovery

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Witwatersrand

Johannesburg, Gauteng, South Africa

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Africa

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M230742

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.